DK277488D0 - PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION - Google Patents

PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION

Info

Publication number
DK277488D0
DK277488D0 DK277488A DK277488A DK277488D0 DK 277488 D0 DK277488 D0 DK 277488D0 DK 277488 A DK277488 A DK 277488A DK 277488 A DK277488 A DK 277488A DK 277488 D0 DK277488 D0 DK 277488D0
Authority
DK
Denmark
Prior art keywords
hmg
phosphorus
preparation
manufacturing
coa reductase
Prior art date
Application number
DK277488A
Other languages
Danish (da)
Other versions
DK277488A (en
Inventor
Donald Steven Karanewsky
Scott Adams Biller
Eric Michael Gordon
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK277488D0 publication Critical patent/DK277488D0/en
Publication of DK277488A publication Critical patent/DK277488A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/36—Amides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44—Amides thereof
    • C07F9/4403—Amides thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4407—Amides of acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK277488A 1987-05-22 1988-05-20 PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION DK277488A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5328187A 1987-05-22 1987-05-22
US10968087A 1987-10-19 1987-10-19

Publications (2)

Publication Number Publication Date
DK277488D0 true DK277488D0 (en) 1988-05-20
DK277488A DK277488A (en) 1988-11-23

Family

ID=26731667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK277488A DK277488A (en) 1987-05-22 1988-05-20 PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION

Country Status (24)

Country Link
JP (1) JP2680347B2 (en)
KR (1) KR880013958A (en)
CN (1) CN88103091A (en)
AU (1) AU610591B2 (en)
BE (1) BE1004193A3 (en)
CH (1) CH676984A5 (en)
DE (1) DE3817375C2 (en)
DK (1) DK277488A (en)
ES (1) ES2009918A6 (en)
FI (1) FI89493C (en)
FR (1) FR2615508B1 (en)
GB (1) GB2205837B (en)
GR (1) GR1000959B (en)
HU (1) HU205125B (en)
IE (2) IE63760B1 (en)
IL (1) IL86464A (en)
IT (1) IT1217685B (en)
NL (1) NL8801330A (en)
NO (1) NO882218L (en)
NZ (1) NZ224733A (en)
PH (1) PH25350A (en)
PL (1) PL154877B1 (en)
PT (1) PT87539B (en)
SE (1) SE503210C2 (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201085B (en) * 1987-05-22 1990-09-28 Squibb & Sons Inc Process for producing phosphor-containing compounds and pharmaceutical compositions containing them as active components
CA2007643A1 (en) * 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination
CA2042526A1 (en) * 1990-06-11 1991-12-12 Adeoye Y. Olukotun Method for preventing a second heart attack employing an hmg coa reductase inhibitor
US5202327A (en) * 1991-07-10 1993-04-13 E. R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors
GB9126144D0 (en) * 1991-12-10 1992-02-12 British Bio Technology Compounds
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
CN1319012A (en) 1998-09-17 2001-10-24 布里斯托尔-迈尔斯斯奎布公司 Methods of treating diabetes with aP2 inhibitors and combinations thereof
US6774112B2 (en) 2001-04-11 2004-08-10 Bristol-Myers Squibb Company Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
US7238671B2 (en) 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
EP1572892A4 (en) 2001-10-18 2007-08-22 Bristol Myers Squibb Co Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US6806381B2 (en) 2001-11-02 2004-10-19 Bristol-Myers Squibb Company Process for the preparation of aniline-derived thyroid receptor ligands
US7057046B2 (en) 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
WO2004037181A2 (en) 2002-10-23 2004-05-06 Bristol-Myers Squibb Company Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
TW200504021A (en) 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US6995183B2 (en) 2003-08-01 2006-02-07 Bristol Myers Squibb Company Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
SI1725234T1 (en) 2004-03-05 2013-04-30 The Trustees Of The University Of Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
TW200611704A (en) 2004-07-02 2006-04-16 Bristol Myers Squibb Co Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
US7145040B2 (en) 2004-07-02 2006-12-05 Bristol-Myers Squibb Co. Process for the preparation of amino acids useful in the preparation of peptide receptor modulators
US7534763B2 (en) 2004-07-02 2009-05-19 Bristol-Myers Squibb Company Sustained release GLP-1 receptor modulators
AR051446A1 (en) 2004-09-23 2007-01-17 Bristol Myers Squibb Co C-ARYL GLUCOSIDS AS SELECTIVE INHIBITORS OF GLUCOSE CONVEYORS (SGLT2)
US7517991B2 (en) 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US7589088B2 (en) 2004-12-29 2009-09-15 Bristol-Myers Squibb Company Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
US7635699B2 (en) 2004-12-29 2009-12-22 Bristol-Myers Squibb Company Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
WO2006076598A2 (en) 2005-01-12 2006-07-20 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US7368458B2 (en) 2005-01-12 2008-05-06 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US7361766B2 (en) 2005-01-12 2008-04-22 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006078697A1 (en) 2005-01-18 2006-07-27 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006113261A2 (en) 2005-04-14 2006-10-26 Bristol-Myers Squibb Company Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
US7521557B2 (en) 2005-05-20 2009-04-21 Bristol-Myers Squibb Company Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
US7317012B2 (en) 2005-06-17 2008-01-08 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoind-1 receptor modulators
US7572808B2 (en) 2005-06-17 2009-08-11 Bristol-Myers Squibb Company Triazolopyridine cannabinoid receptor 1 antagonists
US7452892B2 (en) 2005-06-17 2008-11-18 Bristol-Myers Squibb Company Triazolopyrimidine cannabinoid receptor 1 antagonists
US7629342B2 (en) 2005-06-17 2009-12-08 Bristol-Myers Squibb Company Azabicyclic heterocycles as cannabinoid receptor modulators
US7632837B2 (en) 2005-06-17 2009-12-15 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid-1 receptor modulators
AR056155A1 (en) 2005-10-26 2007-09-19 Bristol Myers Squibb Co ANTAGONISTS OF NON-BASIC MELANINE CONCENTRATION HORMONE RECEIVER 1
WO2007053819A2 (en) 2005-10-31 2007-05-10 Bristol-Myers Squibb Company Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7553836B2 (en) 2006-02-06 2009-06-30 Bristol-Myers Squibb Company Melanin concentrating hormone receptor-1 antagonists
WO2007139589A1 (en) 2006-05-26 2007-12-06 Bristol-Myers Squibb Company Sustained release glp-1 receptor modulators
US7919598B2 (en) 2006-06-28 2011-04-05 Bristol-Myers Squibb Company Crystal structures of SGLT2 inhibitors and processes for preparing same
EP2089355A2 (en) 2006-11-01 2009-08-19 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
PE20090185A1 (en) 2007-03-22 2009-02-28 Bristol Myers Squibb Co PHARMACEUTICAL FORMULATIONS CONTAINING AN SGLT2 INHIBITOR
PE20090696A1 (en) 2007-04-20 2009-06-20 Bristol Myers Squibb Co CRYSTALLINE FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING THEM
CN101820757A (en) 2007-06-01 2010-09-01 普林斯顿大学托管委员会 By regulating host cell metabolic pathways treatment virus infections
US20090011994A1 (en) 2007-07-06 2009-01-08 Bristol-Myers Squibb Company Non-basic melanin concentrating hormone receptor-1 antagonists and methods
CN101808995A (en) 2007-07-27 2010-08-18 百时美施贵宝公司 Novel glucokinase activating agents and using method thereof
BRPI0817211A2 (en) 2007-09-20 2017-05-16 Irm Llc compound compositions as modulators of gpr119 activity
PE20091928A1 (en) 2008-05-29 2009-12-31 Bristol Myers Squibb Co HAVE HYDROXYSUSTITUTED PYRIMIDINES AS NON-BASIC MELANIN-CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS
CN102448456A (en) 2009-03-27 2012-05-09 百时美施贵宝公司 Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
WO2011014520A2 (en) 2009-07-29 2011-02-03 Irm Llc Compounds and compositions as modulators of gpr119 activity
US8575168B2 (en) 2009-10-09 2013-11-05 Irm Llc Compounds and compositions as modulators of GPR119 activity
AU2010319377B2 (en) 2009-11-13 2014-10-23 Astrazeneca Ab Immediate release tablet formulations
DK2498758T3 (en) 2009-11-13 2018-10-15 Astrazeneca Ab TWO-LAYER TABLET FORMULATIONS
MX2012005425A (en) 2009-11-13 2012-06-14 Astrazeneca Uk Ltd Reduced mass metformin formulations.
US8394858B2 (en) 2009-12-03 2013-03-12 Novartis Ag Cyclohexane derivatives and uses thereof
TWI562775B (en) 2010-03-02 2016-12-21 Lexicon Pharmaceuticals Inc Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
ES2559209T3 (en) 2010-04-14 2016-02-11 Bristol-Myers Squibb Company New glucokinase activators and methods of use thereof
BR112013000626B1 (en) 2010-07-09 2019-11-26 Bhv Pharma Inc pharmaceutical formulation and method for preparing a dosage form thereof
US8697739B2 (en) 2010-07-29 2014-04-15 Novartis Ag Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
TWI631963B (en) 2011-01-05 2018-08-11 雷西肯製藥股份有限公司 Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2
WO2014052619A1 (en) 2012-09-27 2014-04-03 Irm Llc Piperidine derivatives and compositions as modulators of gpr119 activity
KR102165224B1 (en) 2012-11-20 2020-10-13 렉시컨 파마슈티컬스 인코퍼레이티드 Inhibitors of sodium glucose cotransporter 1
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN104610262B (en) * 2013-11-01 2017-06-06 上海医药工业研究院 Biphenyl compound, intermediate, preparation method, pharmaceutical composition and its application
MX2017013807A (en) 2015-04-30 2018-03-15 Harvard College Anti-ap2 antibodies and antigen binding agents to treat metabolic disorders.
MX2021000601A (en) 2018-07-19 2021-04-13 Astrazeneca Ab Methods of treating hfpef employing dapagliflozin and compositions comprising the same.
CA3113037A1 (en) 2018-09-26 2020-04-02 Lexicon Pharmaceuticals, Inc. Crystalline forms of n-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oopropan-2-yl)-4-(4-(2-methyl-5-(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl)phenl)butanamide and methods of their synthesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828650B (en) * 1981-12-01 1983-09-28 Hunt Chem Corp Philip A Herbicidal compositions and method using phosphonalkanoic acids, esters and salts thereof
FR2596393B1 (en) * 1986-04-01 1988-06-03 Sanofi Sa HYDROXY-3 DIHYDROXYOXOPHOSPHORIO-4 BUTANOIC ACID DERIVATIVES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
HU201085B (en) * 1987-05-22 1990-09-28 Squibb & Sons Inc Process for producing phosphor-containing compounds and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
SE503210C2 (en) 1996-04-22
FR2615508B1 (en) 1994-11-25
DK277488A (en) 1988-11-23
NL8801330A (en) 1988-12-16
IL86464A (en) 1993-06-10
DE3817375A1 (en) 1988-12-08
HUT49358A (en) 1989-09-28
IE930324L (en) 1988-11-22
FI882384A (en) 1988-11-23
FI89493B (en) 1993-06-30
BE1004193A3 (en) 1992-10-13
GB2205837A (en) 1988-12-21
FI882384A0 (en) 1988-05-20
AU1650888A (en) 1988-11-24
IT1217685B (en) 1990-03-30
SE8801903D0 (en) 1988-05-20
HU205125B (en) 1992-03-30
NO882218D0 (en) 1988-05-20
PL154877B1 (en) 1991-09-30
GR880100331A (en) 1989-02-23
FR2615508A1 (en) 1988-11-25
JPS6456689A (en) 1989-03-03
PT87539B (en) 1992-09-30
JP2680347B2 (en) 1997-11-19
GB8811929D0 (en) 1988-06-22
PL272597A1 (en) 1989-03-06
IE881543L (en) 1988-11-22
IL86464A0 (en) 1988-11-15
NZ224733A (en) 1990-12-21
GR1000959B (en) 1993-03-16
IT8820682A0 (en) 1988-05-20
AU610591B2 (en) 1991-05-23
PT87539A (en) 1989-05-31
FI89493C (en) 1993-10-11
NO882218L (en) 1988-11-23
PH25350A (en) 1991-05-13
DE3817375C2 (en) 1997-04-30
IE63760B1 (en) 1995-06-14
CN88103091A (en) 1988-12-21
SE8801903L (en) 1988-11-23
ES2009918A6 (en) 1989-10-16
GB2205837B (en) 1991-11-20
CH676984A5 (en) 1991-03-28
KR880013958A (en) 1988-12-22

Similar Documents

Publication Publication Date Title
DK277488D0 (en) PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, THEIR USE AND MANUFACTURING AND INTERMEDIATE PRODUCTS IN THE PREPARATION
NO177212C (en) Process for making dough and bread, as well as enzyme preparation for use in the process
DK120188A (en) AMINOMETHYLTHEROCYCLES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
DK328585A (en) MODIFIED SUCCINIMIDES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
NO902272D0 (en) METAL CARBID GOODS AND PROCEDURES IN THEIR PREPARATION.
NO884309D0 (en) STORAGE STABLE YOGURET PRODUCTS AND PROCEDURE FOR THEIR PREPARATION.
DK148590D0 (en) THE HOMOGENES, INSIDE MULTI-COLORED STRUCTURED ARTICLES OR PLATES AND PROCEDURES FOR THEIR PREPARATION
DK317088D0 (en) SUBSTITUTED TRIAZOLINONES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
DK277388D0 (en) PHOSPHORUS HMG-COA REDUCTASE INHIBITORS, INTERMEDIATES AND PROCEDURE
DK698088D0 (en) PIPERIDINYL COMPOUNDS, THEIR USE AND INTERMEDIATES FOR USE IN THE MANUFACTURE OF THESE
NO884270D0 (en) ALKADIENE DERIVATIVES, THEIR MANUFACTURING AND INTERMEDIATE PRODUCTS FOR USE IN THE MANUFACTURING.
DK361288A (en) HYDROXYETHYLAZOLYL DERIVATIVES, THEIR PREPARATION AND USE, AND INTERMEDIATE PRODUCTS FOR THE PREPARATION AND THEIR PREPARATION
IT8820130A0 (en) NAIL ENAMEL OR PAINT HAVING PHOTOCHROMIC CHARACTERISTICS AND THE RELATED PREPARATION PROCEDURE.
DK326085D0 (en) 4-AMINO-2-PHENYLQUINOLINES, THEIR PREPARATION AND USE, AND THE PRODUCTION USED INTERMEDIATES
NO903801L (en) ALKALIPULLUNASE, MICROORGANISM AND PROCEDURES IN THE PREPARATION OF IT.
DK332287D0 (en) ANTIBIOTICS LL-E19020-ALFA AND LL-E19020-BETA, THEIR PREPARATION AND USE, AND MICRO-ORGANISM FOR THE MANUFACTURING
DK39486D0 (en) 4,4-DIAKYL-2-AZETIDINONES, MANUFACTURING AND USING THEREOF, AND THE MANUFACTURING INTERMEDIATE APPLICABLE PRODUCTS AND THEIR PREPARATION
DK610388D0 (en) (6- (HETERO) ARYLOXY-NAPHTHALIN-2-YL-OXY) -ALKANCARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND APPLICATION, AND THE APPLICABLE INTERMEDIATE PRODUCTS AND THEIR PREPARATION
DK440688D0 (en) SULPHONYLAMINOGUANIDINOAZINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
DK192989A (en) 3,4-DIHYDROXYPYRROLIDIN-2-ON DERIVATIVES, THEIR PREPARATION AND APPLICATION, AND THE APPLICABLE INTERMEDIATE PRODUCTS
NO880628L (en) ANNELED AZEPINON AND AZOCINON DERIVATIVES, THE PROCEDURE FOR THEIR MANUFACTURING, MENTALS CONTAINING THEM AND ITS USE, AND INTERMEDIATE PRODUCTS IN THEIR MANUFACTURING.
DK490985A (en) BENZOYLURIC INGREDIENTS, THEIR PREPARATION AND USE, AND THE MANUFACTURING INTERMEDIATE APPLICABLE PRODUCTS AND MANUFACTURING THEREOF
NO900973D0 (en) CASH-FOLDED PACKAGING AND SUBJECT TO USE IN PREPARING THE SAME.
DK264788A (en) AZOLYL-TETRAHYDROFURAN-2-YLIDEN-METHANES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
NO901934D0 (en) FRACTURING MATERIAL, AND USE OF IT IN THE PRODUCTION OF HYDROCARBONES.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment